Invasiveness modulation of glioma cells by copper complex-loaded nanoarchitectures

Agata Zamborlin1, Francesca Pagliari2, Maria Laura Ermini3

  • 1Center for Nanotechnology Innovation@ NEST, Istituto Italiano di Tecnologia, Piazza San Silvestro, 12, Pisa 56127, Italy; NEST-Scuola Normale Superiore, Piazza San Silvestro, 12, Pisa 56127, Italy.

Insights

New copper complex loaded hybrid nano-architectures (CuLNAs) effectively reduce glioma cell migration and invasiveness. This novel approach targets metastasis without affecting cell proliferation, offering a promising strategy for cancer treatment.

Area of Science:

  • Oncology
  • Nanotechnology
  • Biochemistry

Background:

  • Gliomas are highly lethal primary brain tumors known for recurrence and metastasis.
  • Metastasis is a major cause of cancer-related death, yet effective treatments are limited.
  • Copper complexes show antimetastatic potential but can disrupt copper homeostasis.

Purpose of the Study:

  • To develop and evaluate copper complex loaded hybrid nano-architectures (CuLNAs) as targeted antimetastatic agents for gliomas.
  • To investigate the impact of an intracellular copper source delivered via CuLNAs on glioma cell invasiveness.

Main Methods:

  • Synthesis and characterization of novel CuLNAs.
  • Assessment of CuLNAs' effect on glioma cell migration and proliferation.
  • Analysis of epithelial-to-mesenchymal transition (EMT) gene expression.

Main Results:

  • CuLNAs significantly reduced glioma cell migration compared to standard nano-architectures.
  • CuLNAs did not impair glioma cell proliferation.
  • Upregulation of E-cadherin and downregulation of mesenchymal genes indicated an antimigratory effect via EMT modulation.

Conclusions:

  • CuLNAs represent a promising strategy for developing targeted antimetastatic agents by delivering copper intracellularly.
  • Nano-architectures incorporating metal complexes offer a viable approach for creating novel antimetastatic therapies.
  • This approach minimizes off-site effects by enhancing treatment localization.